Clinical Trial Update: Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing raloxifene hydrochloride to placebo for postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• RALOXIFENE HYDROCHLORIDE (RALOXIFENE HYDROCHLORIDE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED